D'ANGELO, Emanuela
 Distribuzione geografica
Continente #
NA - Nord America 1.965
AS - Asia 1.361
EU - Europa 1.003
SA - Sud America 156
AF - Africa 21
OC - Oceania 4
Totale 4.510
Nazione #
US - Stati Uniti d'America 1.895
SG - Singapore 729
IT - Italia 274
CN - Cina 232
IE - Irlanda 230
RU - Federazione Russa 157
VN - Vietnam 151
BR - Brasile 127
SE - Svezia 82
BD - Bangladesh 58
GB - Regno Unito 55
DE - Germania 46
CA - Canada 38
IN - India 33
HK - Hong Kong 29
FR - Francia 23
PL - Polonia 23
JP - Giappone 22
MX - Messico 20
ES - Italia 18
NL - Olanda 18
TR - Turchia 17
LT - Lituania 14
IQ - Iraq 13
FI - Finlandia 12
AT - Austria 11
ZA - Sudafrica 11
PK - Pakistan 10
AR - Argentina 9
BE - Belgio 9
KR - Corea 9
ID - Indonesia 8
SA - Arabia Saudita 8
IR - Iran 7
PH - Filippine 7
JO - Giordania 5
UA - Ucraina 5
BG - Bulgaria 4
CH - Svizzera 4
CZ - Repubblica Ceca 4
PA - Panama 4
PE - Perù 4
RO - Romania 4
VE - Venezuela 4
AE - Emirati Arabi Uniti 3
CL - Cile 3
CO - Colombia 3
CU - Cuba 3
DZ - Algeria 3
IL - Israele 3
MA - Marocco 3
PS - Palestinian Territory 3
TW - Taiwan 3
UZ - Uzbekistan 3
AU - Australia 2
BO - Bolivia 2
DK - Danimarca 2
JM - Giamaica 2
MD - Moldavia 2
MK - Macedonia 2
NZ - Nuova Zelanda 2
OM - Oman 2
TN - Tunisia 2
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BS - Bahamas 1
EC - Ecuador 1
EE - Estonia 1
EG - Egitto 1
GE - Georgia 1
GY - Guiana 1
KG - Kirghizistan 1
MY - Malesia 1
NI - Nicaragua 1
NP - Nepal 1
PT - Portogallo 1
PY - Paraguay 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
ZM - Zambia 1
Totale 4.510
Città #
Singapore 537
Chandler 292
San Jose 284
Ashburn 231
Dublin 230
Beijing 88
Princeton 66
Dallas 65
Jacksonville 58
Los Angeles 58
Ho Chi Minh City 48
New York 45
Pescara 44
Council Bluffs 40
Santa Clara 40
Altamura 35
Hanoi 28
Redondo Beach 27
The Dalles 26
Wilmington 26
Hong Kong 24
Rome 22
São Paulo 19
Milan 18
Moscow 18
Tokyo 17
Warsaw 17
Chieti 16
Montreal 16
Da Nang 15
Brooklyn 14
Munich 14
Washington 14
Chennai 13
Falls Church 13
Amsterdam 12
Buffalo 12
Hefei 12
Atlanta 11
London 11
Orem 11
Toronto 11
Denver 10
Düsseldorf 10
Pavia 10
Stockholm 10
Tongling 10
Nuremberg 9
Boardman 8
Boston 8
Brussels 8
Johannesburg 8
Lauterbourg 8
Poplar 8
San Francisco 8
Ann Arbor 7
Ascoli Piceno 7
Frankfurt am Main 7
Haiphong 7
Kocaeli 7
Lappeenranta 7
Mexico City 7
Querétaro 7
Seoul 7
Ankara 6
City of London 6
Phoenix 6
Shenzhen 6
Amman 5
Baghdad 5
Bologna 5
Vienna 5
Ancona 4
Brusciano 4
Bắc Ninh 4
Chicago 4
Dong Ket 4
Guangzhou 4
Helsinki 4
Houston 4
Hyderabad 4
Jakarta 4
Manchester 4
Nanjing 4
Norwalk 4
Panama City 4
Providence 4
San Agustín del Guadalix 4
Seattle 4
Can Tho 3
Charlotte 3
Chengdu 3
Cincinnati 3
Edinburgh 3
Fortaleza 3
Go Vap 3
Hangzhou 3
Havana 3
Karbala 3
Lahore 3
Totale 2.921
Nome #
PI-RADS in Predicting csPCa: A Comparison Between Academic and Nonacademic Centers 150
Involvement of DNA Base Excision Repair (BER) in Early Stages of Thyroid Carcinogenesis and Its Correlations with Clinical Features and Inflammatory Microenvironment 149
POLE exonuclease domain mutations in endometrial carcinoma: a case report 136
Placental site trophoblastic tumor (PSTT): a case report and review of the literature 127
Extracellular vesicles during the three trimesters of pregnancy 123
Adjuvant osimertinib treatment in patients with early stage NSCLC (IB-IIIA): pathological pathway adaptations 117
Endometrial stromal sarcomas with sex cord differentiation are associated with phf1 rearrangement 116
Endometrioid endometrial carcinomas with microcystic, elongated, and fragmented (MELF) type of myoinvasion: role of immunohistochemistry in the detection of occult lymph node metastases and their clinical significance 113
Dedifferentiated endometrial carcinomas with neuroendocrine features: a clinicopathologic, immunohistochemical, and molecular genetic study 112
Classification of ovarian carcinomas based on pathology and molecular genetics 111
Dual loss of the SWI/SNF complex ATPases SMARCA4/BRG1 and SMARCA2/BRM is highly sensitive and specific for small cell carcinoma of the ovary, hypercalcaemic type 110
Placental histopathology after SARS-CoV-2 infection in pregnancy: a systematic review and meta-analysis 107
A surprising evolution from oral human papillomavirus 16 infection to lymph node metastasis of tonsilar squamous cell carcinoma in an HIV-infected patient 105
The Prognostic Significance of Tumor-Infiltrating Lymphocytes, PD-L1, BRCA Mutation Status and Tumor Mutational Burden in Early-Stage High-Grade Serous Ovarian Carcinoma—A Study by the Spanish Group for Ovarian Cancer Research (GEICO) 102
CD8 down-regulation on cytotoxic T lymphocytes of patients with endometrioid endometrial carcinomas 98
Comparative clinicopathologic and immunohistochemical analysis of uterine sarcomas diagnosed using the World Health Organization classification system 96
Atypical Endometrial Hyperplasia, Low-grade: "Much ADO About Nothing" 96
Loss-of-function variants in myocardin cause congenital megabladder in humans and mice 95
Endometrial carcinoma: 10 years of TCGA (the cancer genome atlas): A critical reappraisal with comments on FIGO 2023 staging 93
Uterine sarcomas: A review 93
Uterine leiomyosarcomas: Tumor size, mitotic index, and biomarkers Ki67, and Bcl-2 identify two groups with different prognosis 92
Expression profiling of 22 genes involved in the PI3K-AKT pathway identifies two subgroups of high-grade endometrial carcinomas with different molecular alterations 90
Stromal signatures in endometrioid endometrial carcinomas 89
BRCA gene amplification in primary peritoneal high-grade serous carcinoma patient with intrinsic resistance to platinum treatment: a case report 85
The FOXO1-miR27 tandem regulates myometrial invasion in endometrioid endometrial adenocarcinoma 85
The fibroid as clinical problem 85
Myometrial invasion and lymph node metastasis in endometrioid carcinomas: Tumor-associated macrophages, microvessel density, and HIF1A have a crucial role 83
Germ cell tumour growth patterns originating from clear cell carcinomas of the ovary and endometrium: a comparative immunohistochemical study favouring their origin from somatic stem cells 83
Diagnostic use of immunohistochemistry in uterine mesenchymal tumors 82
Molecular analyses of juvenile granulosa cell tumors bearing AKT1 mutations provide insights into tumor biology and therapeutic leads 80
Ovarian carcinomas: clinicopathological and molecular characteristics. Comments on the 2014 FIGO staging system 79
Pathology of mixed Müllerian tumours 78
Gene expression analysis identifies two groups of ovarian high-grade serous carcinomas with different prognosis 76
Simultaneous carcinomas of the breast and ovary: Utility of Pax-8, WT-1, and GATA3 for distinguishing independent primary tumors from metastases 75
Ovarian high-grade serous carcinoma with transitional-like (SET) morphology: a homologous recombination-deficient tumor 74
Undifferentiated and Dedifferentiated Endometrial Carcinomas with POLE Exonuclease Domain Mutations Have a Favorable Prognosis 74
Mixed and ambiguous endometrial carcinomas 74
Squamous cell carcinoma of the ovary arising from a mucinous cystic tumor of endocervical (Müllerian) type 74
Mixed endometrial carcinomas with a “low-grade serous”–like component: a clinicopathologic, immunohistochemical, and molecular genetic study 71
Erratum: Small cell carcinoma of the ovary, hypercalcemic type, displays frequent inactivating germline and somatic mutations in SMARCA4 (Nature Genetics (2014) 46 (427-429)) 70
Prognostic significance of FOXL2 mutation and mRNA expression in adult and juvenile granulosa cell tumors of the ovary 69
Small cell carcinoma of the ovary, hypercalcemic type, displays frequent inactivating germline and somatic mutations in SMARCA4 66
Ovarian Carcinomas: Clinicopathologic and Molecular Features With Comments on 2014 FIGO Staging 64
Malignant rhabdoid tumors of the vulva versus epithelioid sarcomas: a clinicopathologic, immunohistochemical, and molecular genetics study 63
30. Metastatic tumors of the ovary. 61
12. Cervical glandular neoplasia 60
19. Uterine smooth muscle tumors. 57
31. The Peritoneum 56
Prognostic Impact of Pathologic Features in Molecular Subgroups of Endometrial Carcinoma 54
Diagnostic challenges in endocervical adenocarcinoma 53
Brenner Tumors and Transitional Cell Tumors of the Ovary. 46
null 44
Ovarian carcinomas: at least five different diseases with distinct histological features and molecular genetics 43
Ovarian Cancer: Pathology and Genetics 31
Role of frozen section in Gynecology Oncology 26
Pathological pathway adaptations for adjuvant osimertinib treatment in patients with early stage NSCLC (IB-IIIA).|Adattamenti dei percorsi patologici in funzione del trattamento con osimertinib in adiuvante nei pazienti con NSCLC in stadio precoce (IB-IIIA) 24
Ovarian Mixed Epithelial–Stromal Tumors 21
Non-neoplastic and Tumor-like Conditions of the Ovary. 19
“Diagnostic accuracy and longitudinal outcomes of PI-RADS 3 lesions: A multi-reader comparison between biparametric and multiparametric MRI” 11
Biomarkers in the diagnosis and treatment of malignant pleural disease: an integrative review 9
Levonorgestrel-releasing intra-uterine device alone for managing early-stage endometrial cancer and endometrial hyperplasia with atypia in patients unfit for surgery: the ENDOIUD study 6
NTRK gene fusions in solid tumors: agnostic relevance, prevalence and diagnostic strategies 6
Mullerian adenosarcoma of the uterus, ovary and peritoneum: Whole transcriptomic digital spatial profiling (DSP) in a cohort of 42 tumors 3
Totale 4.740
Categoria #
all - tutte 22.899
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.899


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20217 0 0 0 0 0 0 0 0 0 0 0 7
2021/2022183 10 2 0 3 6 13 3 10 18 7 21 90
2022/2023720 86 121 31 78 48 115 44 63 74 5 39 16
2023/2024484 28 17 34 11 27 149 116 31 13 24 7 27
2024/2025904 68 154 93 23 31 53 62 50 121 73 89 87
2025/20262.228 200 85 196 227 225 143 335 151 265 179 95 127
Totale 4.740